Cardiac Biomarkers Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Cardiac Biomarkers Market size is expected to grow at an annual average of 7% during 2021-2027. Heart biomarkers are protein molecules that are released into the blood after heart damage or cardiac stress. These biomarkers serve as potential tools to detect a variety of cardiovascular diseases (CVDs), including cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome (ACS). Heart biomarker testing allows doctors to determine a patient’s risk associated with such a disease.

The following segmentation are covered in this report:

By Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute coronary syndrome (ACS)
  • Atherosclerosis
  • Other applications

BY BIOMARKERS TYPE

  • Creatine kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic peptides (BNP and NT-proBNP)
  • Ischemia modified albumin (IMA)
  • Other biomarkers type

Company Profile

  • ABBOTT LABORATORIES
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX, INC.
  • BIO-RAD LABORATORIES, INC.
  • DANAHER CORPORATION
  • F. HOFFMANN-LA ROCHE LTD.
  • PERKINELMER INC.
  • SIEMENS AG
  • THERMO FISHER SCIENTIFIC, INC.
  • TOSOH CORPORATION

Scope of the report

The research study analyses the Cardiac Biomarkers Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

  • Market overview and growth analysis
  • Import and export overview
  • Volume analysis
  • Current market trends and future outlook
  • Market opportunistic and attractive investment segment

Geographic coverage

  • North america market size and/or volume
  • Latin america market size and/or volume
  • Europe market size and/or volume
  • Asia-pacific market size and/or volume
  • Rest of the world market size and/or volume

Key Questions Answered by Cardiac Biomarkers Market Report

  • What was the Cardiac Biomarkers Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
  • What will be the CAGR of Market during the forecast period (2021-2027)?
  • Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
  • Which manufacturer/vendor/players in the Cardiac Biomarkers Market was the market leader in 2020?
  • Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation